{"filing":{"accession_number":"0001493152-26-037360","cik":"0001054102","ticker":"IDXG","company_name":"INTERPACE BIOSCIENCES, INC.","form":"8-K","filing_date":"2026-08-12","report_date":"2026-08-10","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226037360/form8-k.htm"},"events":[{"id":27219,"run_id":24792,"accession_number":"0001493152-26-037360","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses Interpace Biosciences' Q2 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), with a press release announcing revenue of $9.1 million, income from continuing operations of $0.3 million, and key operational metrics including 9% year-over-year thyroid revenue growth. The filing includes condensed consolidated statements of operations and selected balance sheet and cash flow data, which are typical of an earnings release disclosure.","company_name":"INTERPACE BIOSCIENCES, INC.","ticker":"IDXG","filing_date":"2026-08-12","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":28646,"accession_number":"0001493152-26-037360","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses Interpace Biosciences' Q2 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), with a press release announcing revenue of $9.1 million, income from continuing operations of $0.3 million, and key operational metrics including 9% year-over-year thyroid revenue growth. The filing includes condensed consolidated statements of operations and selected balance sheet and cash flow data, which are typical of an earnings release disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T20:19:21.200015+00:00","company_name":"INTERPACE BIOSCIENCES, INC.","ticker":"IDXG","filing_date":"2026-08-12"}]}